A noninvasive method for predicting clinically significant prostate cancer using magnetic resonance imaging combined with PRKY promoter methylation level: a machine learning study.
Journal Information
Full Title: BMC Med Imaging
Abbreviation: BMC Med Imaging
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Diagnostic Imaging
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
".Declarations Ethics approval and consent to participateAll experiments in this study was performed in accordance with relevant guidelines and regulations. This study was approved by the Ethics Committees of the Second Affiliated Hospital of Soochow University in 2022. The approval number is JDLK202205901. All the patients were informed about and provided consent for the study. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
"Funding This study is supported by grants for Jin Zhu from the Gusu Talent Program (No. GSWS2021016)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025